Bridget A. Bagert, MD, MPH

August 04, 2022

Experts in neurology share their hopes for the future of multiple sclerosis treatment and discuss unmet needs and novel targets.

August 04, 2022

Amit Bar-Or, MD, FRCPC, and Bridget A. Bagert, MD, share their opinions on how to move investigative treatments for multiple sclerosis off the laboratory bench and into clinical practice.

August 04, 2022

Doctors in neurology comment on the hidden symptoms of multiple sclerosis and debate whether they should be treatment targets.

July 28, 2022

Experts in neurology comment on clinical trial design considerations and discuss novel imaging techniques and biomarkers that they consider most important to investigate for multiple sclerosis.

July 28, 2022

Bridget A. Bagert, MD, leads a discussion on the ideal patient populations for using a potential vaccine for multiple sclerosis, and the panel comments on other factors to consider when administering vaccines.

July 21, 2022

Amit Bar-Or, MD, FRCPC, discusses the potential impact vaccination against Epstein-Barr virus could play on multiple sclerosis rates, highlighting recent investigations.

July 21, 2022

Experts in neurology discuss screening and diagnostic considerations for a patient newly diagnosed with multiple sclerosis.

July 14, 2022

Bridget A. Bagert, MD, and Ahmed Obeidat, MD, PhD, examine the clinical implications of a causal link between Epstein-Barr virus and multiple sclerosis and provide insight on how to discuss this link with patients.

July 14, 2022

Lawrence Steinman, MD, discusses his recent publication, which demonstrated the causal link between Epstein-Barr virus and multiple sclerosis, highlighting key findings and conclusions.

July 07, 2022

Ahmed Obeidat, MD, PhD, comments on other viruses that have been linked to the development of multiple sclerosis and discusses how they can be both protective and detrimental.